nicardipine has been researched along with sulconazole in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, B; Helfand, BT; McGovern, SL; Shoichet, BK | 1 |
| Doman, TN; McGovern, SL; Seidler, J; Shoichet, BK | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Colby, DW; Collins, SR; Feng, BY; May, BC; Prusiner, SB; Shoichet, BK; Toyama, BH; Weissman, J; Wille, H | 1 |
| Bakmiwewa, SM; Ball, HJ; Fatokun, AA; Hunt, NH; Payne, RJ; Tran, A | 1 |
5 other study(ies) available for nicardipine and sulconazole
| Article | Year |
|---|---|
A specific mechanism of nonspecific inhibition.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Centrifugation; Enzyme Inhibitors; Fluorescence; Heterocyclic Compounds; Inhibitory Concentration 50; Light; Microscopy, Confocal; Microscopy, Electron, Scanning; Octoxynol; Scattering, Radiation; Thermodynamics | 2003 |
Identification and prediction of promiscuous aggregating inhibitors among known drugs.
Topics: Antifungal Agents; beta-Lactamase Inhibitors; Chemical Phenomena; Chemistry, Physical; Chymotrypsin; Enzyme Inhibitors; Kinetics; Light; Malate Dehydrogenase; Models, Molecular; Molecular Conformation; Scattering, Radiation; Structure-Activity Relationship | 2003 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Small-molecule aggregates inhibit amyloid polymerization.
Topics: Acetophenones; Animals; Benzopyrans; beta-Lactamase Inhibitors; beta-Lactamases; Clioquinol; Congo Red; Detergents; Flavanones; Mice; Microscopy, Electron, Transmission; Molecular Structure; Molecular Weight; Particle Size; Peptide Termination Factors; Phenolphthaleins; Phthalimides; Prions; Recombinant Proteins; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Sensitivity and Specificity; Structure-Activity Relationship | 2008 |
Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
Topics: Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; HEK293 Cells; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Substrate Specificity | 2012 |